PS

Peter Seiler

Board Member at OMEICOS Therapeutics

No bio yet


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


OMEICOS Therapeutics

OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.


Headquarters

Berlin, Germany

Employees

11-50

Links